Skip to main content
Premium Trial:

Request an Annual Quote

Natera Partners With One Lambda to Distribute Kidney Transplant Rejection Test

NEW YORK (GenomeWeb) – Natera said today that it has struck a distribution deal with Thermo Fisher Scientific's One Lamda to co-distribute its cell-free DNA-based kidney transplant rejection test in the US.

Parisa Khosropour, president of transplant diagnostics at Thermo Fisher Scientific, said in a statement that Natera's cfDNA test "complements [its] existing transplant offerings and enables us to provide a more advanced portfolio for monitoring kidney rejection."

Natera CEO Steve Chapman said that the firm would still have its own direct sales team when it launches its test this year, but would also be able to leverage One Lambda's commercial infrastructure.

The company published a validation study of its kidney transplant rejection assay in the Journal of Clinical Medicine last December, retrospectively analyzing 300 plasma samples from 193 patients. Last month, Natera said that it had submitted a dossier to the Centers for Medicare and Medicaid Services for reimbursement and anticipated that its test would be priced at a similar rate to CareDx's cfDNA assay for kidney transplant rejection of $2,800.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.